Using voice and face recognition to screen for allergic rhinitis

Multimodal Data-assisted Primary Screening for Allergic Rhinitis Based on Voice Recognition and Face

This study is testing whether using voice and facial recognition can help doctors better identify allergic rhinitis in patients with chronic rhinitis.

Quick facts

• Study type: Observational
• Enrollment: 1500 (estimated)
• Ages: 8 Years to 80 Years
• Sex: All
• Sponsor: Huazhong University of Science and Technology (other)
• Drugs / interventions: immunotherapy
• Locations: 1 site (Wuhan, Hubei)
• Trial ID: NCT06474923 on ClinicalTrials.gov

What this trial studies

This study aims to improve the screening process for allergic rhinitis by collecting facial images and voice recordings from patients diagnosed with chronic rhinitis. The collected data will be analyzed alongside clinical examination results to develop a predictive model that distinguishes between allergic and non-allergic rhinitis. By enhancing public awareness and understanding of allergic rhinitis, the study seeks to facilitate timely and appropriate treatment, thereby reducing misdiagnosis and unnecessary healthcare costs. The effectiveness of the model will be evaluated based on its ability to accurately identify the type of rhinitis.

Who should consider this trial

Good fit: Ideal candidates for this study are Chinese individuals aged 8-80 years who have been clinically diagnosed with chronic rhinitis and can cooperate with the study procedures.

Not a fit: Patients with a history of serious systemic diseases, autoimmune disorders, or those currently undergoing specific treatments for allergies may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could lead to quicker and more accurate diagnoses of allergic rhinitis, improving patient outcomes and reducing healthcare costs.

How similar studies have performed: While the approach of using multimodal data for screening is innovative, similar studies have shown promise in improving diagnostic accuracy in other conditions.

Eligibility criteria

Inclusion Criteria:

1. Subjects understood the purpose and procedure of the trial and signed an informed consent form, and voluntarily participated in this study;
2. Subjects were initially clinically diagnosed with chronic rhinitis;
3. Subjects were aged 8-80 years old, limited to Chinese nationality, and were able to perform basic examinations and cooperate with face photography and voice collection.

Exclusion Criteria:

1. Those who received systemic immunotherapy, used systemic or local glucocorticoids as well as leukotriene receptor antagonists within one month;
2. Those who suffer from immune system diseases, autoimmune diseases, allergic diseases or allergies and have a history of food allergy;
3. Other serious systemic diseases, such as active tuberculosis, rheumatic heart disease, congenital heart disease, arthritis, nephritis, hypertension, psychosis, dermatitis, epilepsy and so on;
4. Women during lactation and pregnancy;
5. History of upper respiratory tract infection or more serious infectious diseases within three months;
6. Those who are currently participating in another clinical study or have participated in another clinical study within 90 days;
7. Other patients who, in the judgment of the clinician, are not suitable for inclusion in the study.

Where this trial is running

Wuhan, Hubei

• Professor of Otolaryngology-Head & Neck Surgery Vice Director Department of ENT Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Affiliation: Huazhong University of Science and Technology — Wuhan, Hubei, China (RECRUITING)

Study contacts

• Study coordinator: Zheng Liu, Doctor

Conditions: Body Image, Speech Sound Disorder